B
BRA
vs
W
WIG20
Over the past 12 months, BRA has underperformed WIG20, delivering a return of 0% compared to the WIG20's +29% growth.
Stocks Performance
BRA vs WIG20
Performance Gap
BRA vs WIG20
Performance By Year
BRA vs WIG20
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Braster SA
Glance View
Braster SA engages in the development and manufacturing of medical devices for self-examination. The firm provides research and development on breast cancer. The company applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The firm cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.